BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Jurkat Cells

Below is an extended Jurkat Cells research listing. Click here to return to the Jurkat Cells main in depth entry.

Recent Publications on Jurkat Cells:

Selective targeting of leukemic cells growth in vivo and in vitro using a gene silencing approach to diminish S-adenosylmethionine (SAMe) synthesis.
We exploited the fact that leukemic cells utilize significantly higher...
Direct Link
30th August, 2008
Molecular Genetics, Biochemistry and Microbiology, University of
Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat).
Harmful algal blooms (HABs) of the toxic dinoflagellate, Karenia brevis,...
Direct Link
30th August, 2008
Marine Immunology Program, Center for Shark Research, Mote Marine
Recombinant carcinoembryonic antigen as a reporter gene for molecular imaging.
PURPOSE: Reporter genes can provide a way of noninvasively assessing gene...
Direct Link
23rd August, 2008
Crump Institute for Molecular Imaging, Department of Molecular and Medical
[Expression of A Tumor Related Gene chp2 in Leukemia Cells.] 23rd August, 2008
State Key Laboratory of Experimental Hematology, Institute of Hematology
PPARalpha AND PPARgamma EFFECTIVELY PROTECT AGAINST HIV-INDUCED INFLAMMATORY RESPONSES IN BRAIN ENDOTHELIAL CELLS.
Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors...
Direct Link
20th August, 2008
Molecular Neuroscience and Vascular Biology Laboratory, Department of
Inhibition of IkappaB Kinase-beta and Anticancer Activities of Novel Chalcone Adamantyl Arotinoids.
On the basis of the observations that chalcone 7 (MX781) and some related...
Direct Link
16th August, 2008
Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function.
Aberrant N-linked glycans promote the malignant potential of cells by...
Direct Link
15th August, 2008
Ontario Cancer Institute, Princess Margaret Hospital, Canada.
Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals.
The antiapoptotic protein Bcl-2 inhibits Ca2+ release from the endoplasmic...
Direct Link
13th August, 2008
Department of Medicine, Case Western Reserve University, Cleveland, OH
[Preparation and activity detection of monoclonal antibody against anti-CD3 ScFv] 9th August, 2008
State Key Laboratory of Experimental Hematology, Institute of Hematology,
[Effects of beta-catenin-specific siRNA interference on Jurkat and K562 cells] 9th August, 2008
State Key Laboratory of Hematology, Institute of Hematology, Blood Disease
Proteome identification of binding-partners interacting with cell polarity protein Par3 in Jurkat cells. 8th August, 2008
School of Life Science, East China Normal University, Shanghai 200062,
T Lymphocytes are Targets for Platelet- and Trophoblast-Derived Microvesicles During Pregnancy.
Microvesicles (MVs) can derive from several cell types and their membranes...
Direct Link
8th August, 2008
Department of Genetics, Cell and Immunobiology, Semmelweis University,
Immune effects of four Fusarium-toxins (FB(1), ZEA, NIV, DON) on the proliferation of Jurkat cells and porcine lymphocytes: in vitro study.
Microvesicles (MVs) can derive from several cell types and their membranes...
Direct Link
7th August, 2008
Department of Pathology and Animal Health, Faculty of Veterinary Medicine,
Contribution of alpha(4)beta(1) integrin to the antiallergic effect of levocabastine.
Levocabastine is an antiallergic drug acting as a histamine H1-receptor...
Direct Link
6th August, 2008
Department of Medicine, Health Science Campus, University of Toledo, OH,
Chromatin profiling across the human tumour necrosis factor gene locus reveals a complex, cell type-specific landscape with novel regulatory elements.
The TNF locus on chromosome 6p21 encodes a family of proteins with key...
Direct Link
26th July, 2008
Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional